Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News
AstraZeneca gains on getting nod from CDSCO to import new drug Eculizumab | Capital Market News - Business Standard
AstraZeneca Pharma share price rises 3% on CDSCO nod for Eculizumab | News on Markets - Business Standard
AstraZeneca's rare disease portfolio gets a boost as company prepares to launch blockbuster drug in India
Kepler Capital Remains a Hold on AstraZeneca (AZN)
ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN By Investing.com
Park Avenue Securities LLC Acquires 14,711 Shares of AstraZeneca PLC (NASDAQ:AZN)
AstraZeneca PLC (NASDAQ:AZN) Stock Position Reduced by Assenagon Asset Management S.A.
Pines Wealth Management LLC Invests $378,000 in AstraZeneca PLC (NASDAQ:AZN)
Chemistry, manufacturing and controls strategies for using novel excipients in lipid nanoparticles
Cellectis files to sell 44M ordinary shares for holders
Cox Capital Mgt LLC Grows Position in AstraZeneca PLC (NASDAQ:AZN)
Community Trust & Investment Co. Acquires 8,903 Shares of AstraZeneca PLC (NASDAQ:AZN)
Short Interest in AstraZeneca PLC (OTCMKTS:AZNCF) Expands By 116.7%
SpringWorks Therapeutics' SWOT analysis: biotech stock shows promise amid challenges By Investing.com
Is AstraZeneca (AZN) Top Stock Pick in Billionaire George Soros' Portfolio?
Trade Tracker: Jim Lebenthal buys Astrazeneca
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN By Investing.com
Tlwm Has $1.09 Million Stock Position in AstraZeneca PLC (NASDAQ:AZN)
Miracle Mile Advisors LLC Boosts Position in AstraZeneca PLC (NASDAQ:AZN)
Contact Levi & Korsinsky by February 21, 2025 Deadline to Join Class Action Against AstraZeneca PLC (AZN) | Morningstar
Latest news
Bitcoin Price Action Muted: A Complete Guide on How to Buy Bitcoins in the UK
Week Ahead: Japanese CPI and the BoJ rate hike on the watch, All eyes on the Canada inflation and Trump inauguration